{"ticker": {"uuid": "e8c488f3-9429-40a6-b18b-54cad1e6fb15", "symbol": "2171", "name": "CARsgen Therapeutics Holdings Limited", "exchange": "HKG", "country": "HK", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "Mineralys Therapeutics CMO Rodman sells $65,781 in stock", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxPS0ZYbXpNbVhhRWhKcVVES1dZY0xnb1JlX2ZPMDZDQXJqeUlYd0pXc0lVSF9yV1lTdnZqd0tBVF9BYmxkOGI3LThvMXpESTloNnJ3VnIzRnlOb25tR1M3QjdUM1BzOXNJdWRJMzlncGlhWHMya2FfTTJ0N0RTRm42eDZPUGd3VFVOTmg0cTNCdko2ZDYwN3VESkk4MW9QMlF6bDI2aEZNVnlSOUFRdEwtVGI2Q3R4a3pOa2xV?oc=5", "source_name": "Investing.com", "published_at": "2026-07-10T23:40:28+00:00", "published_display": "10 Jul 2026 23:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mineralys Therapeutics (MLYS) CMO sells 2,171 shares after option exercise", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxOVHZsak9xUnpPU1l0b1FRdmZkZ01yZXprZVgzQjZqakZKX2lMNS1RcDVGLWlqREtSc1JCelk5ZlFHLUZDZ0NPUVhIWjRJNTJ4c094ZkRaX0hiV3RtX1hYaGFMRTNFUHN2bFpwWEZzTzNpTS1VeDdMM3hHYldJUzBmdHRXZHRYbzRlZVYxYnVpU3pZNEFpVTZmX0VIWEtFRWkxQUg1T3JqdmJha2J4QVlvYlgyZkUxLUYzTHFNRQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-10T23:15:53+00:00", "published_display": "10 Jul 2026 23:15", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CARsgen Therapeutics Holdings Limited (stock code: 2171.HK) repurchased 270,000 shares on July 7 at a total cost of HK$4.0603 million.", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxQQ24xZmpQcUlGWGlDX3k0SjZ2dksyUF9pZXlpSDhEc0h0T3pqNWl1VnNZZEhZbmJJREFlVFNTd3BGNFZXOWVHWjAzVnI4T2ZsUnlwOEVOX3lPYlF5OWlxRXZUbFM0eC0yMkdxV3gteDRmZ0MxUzJvc3ZROHdMU01qaFgzSHZtTEMtcmFQNE1RQlNxZExObXlYOFIzajNwVW9hYlp2eXlkWEZ2SFdiUXUxMmpVR3Z1dXJJ?oc=5", "source_name": "Moomoo", "published_at": "2026-07-07T14:13:17+00:00", "published_display": "07 Jul 2026 14:13", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CARsgen Therapeutics (SEHK:2171) Is Up 20.8% After First Solid Tumor CAR T Approval - What's Changed", "summary": "", "url": "https://news.google.com/rss/articles/CBMi-wFBVV95cUxQZ2RIVFJQNWJPODAtanFDZUhKZDAyelN3bHFCeGk0TE5aa0dOYzBRdFEyeHpVOTc0ei1QVDhjU3JmY0t4UmlwN0lYNkVSMEpOTGhrOFpoa2p1LUQ2akRCUkVzNzhlYXRRZXd3MTdleGZpdnVTM3RyN3g4OTZXdWZvVXVyXzFUUnlreTJKVktrYVZKbDQzMDlyRE91VUlZTDFjV2ZvdHhYTDU0QS1YcFpnbnF0M3JKN0RxVlZwQnJ4OGFiYnp2T080VFh3eTg4TFppU3l5Q0RXclpSV2dXOGVOcTJVUVktbHp1WURrUjVJQktwb0NkM2tnaFc4UdIBgAJBVV95cUxQQWM4X1d3Vjdyc0hRRDNHOXVhTkI2bDIwOUFpUWFTQ3d5TElTbHFIbVk2ckd3QlpTTEhTT0FnRG9BV1QyNDBpb1FlSkhuWjVGTmQzenhaaE1iS3dhb1pkeUltRTktVTFQS1c0YlhCRlJaaUdSSWMxMkR3cDhFMlNsbTBrQ2h5NldyT1RweGk2cU1XS1ZCUXB1aXAzVEtPRmdfeTFwSU1tcGkwZXJiZ0hUTjhPWHF6UVhrdWdPdnlsSmstdmRBVWhlVVNCMDY0SEFpdUpfb2kycG9rM2NSYW1QMi1xOERUSUVBR1pkamk5aG94aExCV1ZuMGJ0OVBPcWY0?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-03T07:00:00+00:00", "published_display": "03 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Following Satri Cel Approval Is CARsgen Therapeutics Holdings (SEHK:2171) Fully Priced?", "summary": "", "url": "https://news.google.com/rss/articles/CBMi-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?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-29T20:32:06+00:00", "published_display": "29 Jun 2026 20:32", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hong Kong Stock Market Update | CARsgen Therapeutics-B (02171) Rises Over 3% in Afternoon Trading; Plans to Repurchase Up to 5% of Shares", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxPVm5fc0x3eWJVckFQaTBHSGU3TVZCa0s5cVdKVTV0S1hMMnZUdzdvajFlWkJvMEQ3M0lJYlVTRkxUREwwX2JQWW9LSnJ5NTlEQThRWklILWxsX19nN3NKaVNJaHVMb2o1SkxLOXllM0pPU2hoWUN2TkJvT2ZvYUtlaU9WM3o5Y1p1Q0Z1M21ya0M0SE1vbnhNYndIMm5kYU9pQUdCWTFrQVRDQQ?oc=5", "source_name": "Moomoo", "published_at": "2026-06-25T07:00:00+00:00", "published_display": "25 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CARsgen Presents Allogeneic CAR T-cell Products CT0596 and CT1190B at EHA 2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMizwFBVV95cUxOLXhfYzNVY0JhcEhxNVFYVjBsT3hpNUJXcW45S09SRE9lX3VPdXlyeXJja0R6XzNaQ0VCcy1DNjlQZjhiRlJNUlhBRFlNaEtaTTZia0N2WnpjZ2I5elI4cmtJM1lwYXQ4bDRYMXFhMnhvWmJUX181MkN2bXFtZTdkN3BkaS1ETmRTNHhlTnhiamR6Q291T3ltSFRteDd0X3hQOWlCRVlXWHQzOG5KR3FIQjlwT2F1NlRURXA4ZHZqNHFQWVJJSk10U2YwYVdScUE?oc=5", "source_name": "PR Newswire", "published_at": "2026-06-14T07:00:00+00:00", "published_display": "14 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Long-term Follow-up Results of CARsgen's Satri-cel as Sequential Therapy After First-Line Treatment for Gastric Cancer Presented at the 2026 ASCO Annual Meeting", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgJBVV95cUxPUG5UemxxYU9LeE5wWmVDUUl6anhvUUFrcHZISVZaQ3ZDOFhUQ3BvOTMwZmx6djF2VmRvTXdXSXBxcDNOcDQ0NWpmY3A4S2pIM3NNWUltNGlUTWQzbWNmMDdtVGhySWxhMWJHRVFzbTBmMWdXS1hPNU56U191dnp5a0xWLWNCOGtGTzFIVHZVLV8yc1ItNm9OUzJYNmxSdEpWVXNXam5MR1JPUjZpc3UxNEVZTjlRWWlpNU9TeDJObHNvOXRPSkxQdFktRzFtRC1RMTJ2Z0RmaERTdFVhVHFBMHlnUmE0dTlQRURkMEdhVHZYT1B4STFITFZHRW1MLTVvWlRnbUdFZ20zQ1o2eTR2cTFubWZFOGcxdlM0MjFnVHBNMEtUY1E?oc=5", "source_name": "BioSpace", "published_at": "2026-06-01T07:00:00+00:00", "published_display": "01 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Multiple affiliate sales and option exercises at Mineralys Therapeutics (MLYS)", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNMWVGWDgyRFczZVdyVl90bTRwdjVxaHVHb1p0TFJ1UVNBOHBFQVJwV0FFMVFMMDROT1lhU2xyanNXRHZDSENBUk5lWVhQNDdYOUJBVDJYaXBmRUNqOFFDVDNCR1I5dzF4RnV6MmJGWEJ6dTR3QTcyZ1ZjQkUzazUzUDNfckw4VUVKRC0tLUpyV2ZtRGotRHk4OWhHQmYwa0U0YzdfYXpn?oc=5", "source_name": "Stock Titan", "published_at": "2026-05-13T07:00:00+00:00", "published_display": "13 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Carsgen\u2019s zevor-cel CAR T shows long-term survival in MM", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOa2UtdEpNckphdjgwM2JFS0dYSzM2bGZtWU5GZUNPN3BHNngzZThzSTBEbTdSWE13dVlzOXEwQVlURXNpV29pazNTNERLY2t2UzdrQWhGRGxqNm5tTUhKTHBLV3I3YnkzZzMyQUJzS1RmdnV3TzU1WDRHZ19BaDVOV3NxNktKTU9FaGN0WEJFa1dzTS1PbmsxSkFlSkM?oc=5", "source_name": "BioWorld News", "published_at": "2025-09-23T07:00:00+00:00", "published_display": "23 Sep 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CARsgen Therapeutics Announces 2025 Interim Results", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxQRVZ0STNQMjdUZ0F2eG5NUUQ5cVU2cFRDVi1jaWJrdzBjSnRuSS1yS2cybWRHWmNKb2FnaFppRXotTTJaTlpUMkpmSXNoMkY1QWVibXJXZVNxQ3Iza2hTZEktMG5PWWJvVHZYLUZqYVlGTTh1OWZxTGZkajZ3WnVxVWU3a2dvVHVKNDNTWWJBazVXMDAxOXVaY0tJTFhpbkU4YmV5bk9xNV81UTQ?oc=5", "source_name": "PR Newswire", "published_at": "2025-08-14T07:00:00+00:00", "published_display": "14 Aug 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CARsgen Successfully Defends Its GPC3 CAR-T Patent at the EPO", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxOZE9uU0ZMWkdHLXNvRDdnLU5qemZHaHBJZTB6ZlpVa1hKcktTYXZCR291bzBZVUhfNHp0YU9zV3RxWXFaeHd3SVItZlNVQnlJQ25ycGI1SDVGYTgwMVBBQV95VTYwZmFWZU80bUxIQzZyZzI5bHlSU1R3MEFLMktNUVZtVzVZM1dJd2puanhzcmVxY1I0WFdsdlVNSHZjZTh0cms3ZHRLLUpYUXBoRGktVUtQZmRaNDEx?oc=5", "source_name": "PR Newswire", "published_at": "2025-07-13T07:00:00+00:00", "published_display": "13 Jul 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CARsgen touts phase 2 stomach cancer win for cell therapy, revs up for China submission", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxNc2JjRmpRNWw2c0FQT1EtMXg4T0NFcUZHRHFrZ1JYb1BmM1NONlRzNUlpTkVvNVljVWJ6aFpoMHZMYk9YcXBkR0Zvb1Fob1ZxTzJrM0xoTTI3c25vV01WYzU3SjlPdnliOUZMODhuMVB0aTN2Nk05M3VJSHJMUEdGQ09SQ0U4ZGJpekIyRmFVVnJ1R0xndGZRU1JvdVJpM0pEcVZ2a3F5S3ZSSjR0SUplWEVuTHo2WHFQbVpv?oc=5", "source_name": "Fierce Biotech", "published_at": "2025-01-02T08:00:00+00:00", "published_display": "02 Jan 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "FDA Removes Clinical Holds Previously Placed on 3 of CARsgen's Oncology Cell Therapies", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxQNkVKZTU1TXVVNWk1cWdjanNrWTQtaE9fdDZ4cnNERGlXaHdlZmxTaGJRUDMyeVZ2RGdKalV0bGVnN3ByUzdxVTc1V01pdnZ5bWRCenFFSWVZREdHZE5jVWVOcS05M1pCV2lRSzNacWdENDNpTFczQ2hja1cyR1Axd3BBZFJ3bmlORDBNS3JWaE10S195VFpwMW9MQjI?oc=5", "source_name": "CGTLive\u00ae", "published_at": "2024-11-07T08:00:00+00:00", "published_display": "07 Nov 2024 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CARsgen Therapeutics officially listing on HKEX", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxQTFB5bnpOUnU2clR2X00yNU9PNGNvQ1lLUDhxMEJWdHkyVExWZUFoNHUwUUNWY1A5dGpRdWhHX2VDSXYyUHlmcFFaQUwwUHAzVDhNNU5HSDQwS3lxczE5Tnp0NnFYemphcWpidmJYVldhM1FnSlFtMkI3S2gzVlVLTmNSczJjTWpmR2hfX21xRndaZTJq?oc=5", "source_name": "BioPharma APAC", "published_at": "2021-06-19T07:00:00+00:00", "published_display": "19 Jun 2021 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Mineralys Therapeutics CMO Rodman sells $65,781 in stock", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxPS0ZYbXpNbVhhRWhKcVVES1dZY0xnb1JlX2ZPMDZDQXJqeUlYd0pXc0lVSF9yV1lTdnZqd0tBVF9BYmxkOGI3LThvMXpESTloNnJ3VnIzRnlOb25tR1M3QjdUM1BzOXNJdWRJMzlncGlhWHMya2FfTTJ0N0RTRm42eDZPUGd3VFVOTmg0cTNCdko2ZDYwN3VESkk4MW9QMlF6bDI2aEZNVnlSOUFRdEwtVGI2Q3R4a3pOa2xV?oc=5", "source_name": "Investing.com", "published_at": "2026-07-10T23:40:28+00:00", "published_display": "10 Jul 2026 23:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mineralys Therapeutics (MLYS) CMO sells 2,171 shares after option exercise", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxOVHZsak9xUnpPU1l0b1FRdmZkZ01yZXprZVgzQjZqakZKX2lMNS1RcDVGLWlqREtSc1JCelk5ZlFHLUZDZ0NPUVhIWjRJNTJ4c094ZkRaX0hiV3RtX1hYaGFMRTNFUHN2bFpwWEZzTzNpTS1VeDdMM3hHYldJUzBmdHRXZHRYbzRlZVYxYnVpU3pZNEFpVTZmX0VIWEtFRWkxQUg1T3JqdmJha2J4QVlvYlgyZkUxLUYzTHFNRQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-10T23:15:53+00:00", "published_display": "10 Jul 2026 23:15", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CARsgen Therapeutics Holdings Limited (stock code: 2171.HK) repurchased 270,000 shares on July 7 at a total cost of HK$4.0603 million.", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxQQ24xZmpQcUlGWGlDX3k0SjZ2dksyUF9pZXlpSDhEc0h0T3pqNWl1VnNZZEhZbmJJREFlVFNTd3BGNFZXOWVHWjAzVnI4T2ZsUnlwOEVOX3lPYlF5OWlxRXZUbFM0eC0yMkdxV3gteDRmZ0MxUzJvc3ZROHdMU01qaFgzSHZtTEMtcmFQNE1RQlNxZExObXlYOFIzajNwVW9hYlp2eXlkWEZ2SFdiUXUxMmpVR3Z1dXJJ?oc=5", "source_name": "Moomoo", "published_at": "2026-07-07T14:13:17+00:00", "published_display": "07 Jul 2026 14:13", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CARsgen Therapeutics (SEHK:2171) Is Up 20.8% After First Solid Tumor CAR T Approval - What's Changed", "summary": "", "url": "https://news.google.com/rss/articles/CBMi-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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-03T07:00:00+00:00", "published_display": "03 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Following Satri Cel Approval Is CARsgen Therapeutics Holdings (SEHK:2171) Fully Priced?", "summary": "", "url": "https://news.google.com/rss/articles/CBMi-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?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-29T20:32:06+00:00", "published_display": "29 Jun 2026 20:32", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hong Kong Stock Market Update | CARsgen Therapeutics-B (02171) Rises Over 3% in Afternoon Trading; Plans to Repurchase Up to 5% of Shares", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxPVm5fc0x3eWJVckFQaTBHSGU3TVZCa0s5cVdKVTV0S1hMMnZUdzdvajFlWkJvMEQ3M0lJYlVTRkxUREwwX2JQWW9LSnJ5NTlEQThRWklILWxsX19nN3NKaVNJaHVMb2o1SkxLOXllM0pPU2hoWUN2TkJvT2ZvYUtlaU9WM3o5Y1p1Q0Z1M21ya0M0SE1vbnhNYndIMm5kYU9pQUdCWTFrQVRDQQ?oc=5", "source_name": "Moomoo", "published_at": "2026-06-25T07:00:00+00:00", "published_display": "25 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CARsgen Presents Allogeneic CAR T-cell Products CT0596 and CT1190B at EHA 2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMizwFBVV95cUxOLXhfYzNVY0JhcEhxNVFYVjBsT3hpNUJXcW45S09SRE9lX3VPdXlyeXJja0R6XzNaQ0VCcy1DNjlQZjhiRlJNUlhBRFlNaEtaTTZia0N2WnpjZ2I5elI4cmtJM1lwYXQ4bDRYMXFhMnhvWmJUX181MkN2bXFtZTdkN3BkaS1ETmRTNHhlTnhiamR6Q291T3ltSFRteDd0X3hQOWlCRVlXWHQzOG5KR3FIQjlwT2F1NlRURXA4ZHZqNHFQWVJJSk10U2YwYVdScUE?oc=5", "source_name": "PR Newswire", "published_at": "2026-06-14T07:00:00+00:00", "published_display": "14 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Long-term Follow-up Results of CARsgen's Satri-cel as Sequential Therapy After First-Line Treatment for Gastric Cancer Presented at the 2026 ASCO Annual Meeting", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgJBVV95cUxPUG5UemxxYU9LeE5wWmVDUUl6anhvUUFrcHZISVZaQ3ZDOFhUQ3BvOTMwZmx6djF2VmRvTXdXSXBxcDNOcDQ0NWpmY3A4S2pIM3NNWUltNGlUTWQzbWNmMDdtVGhySWxhMWJHRVFzbTBmMWdXS1hPNU56U191dnp5a0xWLWNCOGtGTzFIVHZVLV8yc1ItNm9OUzJYNmxSdEpWVXNXam5MR1JPUjZpc3UxNEVZTjlRWWlpNU9TeDJObHNvOXRPSkxQdFktRzFtRC1RMTJ2Z0RmaERTdFVhVHFBMHlnUmE0dTlQRURkMEdhVHZYT1B4STFITFZHRW1MLTVvWlRnbUdFZ20zQ1o2eTR2cTFubWZFOGcxdlM0MjFnVHBNMEtUY1E?oc=5", "source_name": "BioSpace", "published_at": "2026-06-01T07:00:00+00:00", "published_display": "01 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Multiple affiliate sales and option exercises at Mineralys Therapeutics (MLYS)", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNMWVGWDgyRFczZVdyVl90bTRwdjVxaHVHb1p0TFJ1UVNBOHBFQVJwV0FFMVFMMDROT1lhU2xyanNXRHZDSENBUk5lWVhQNDdYOUJBVDJYaXBmRUNqOFFDVDNCR1I5dzF4RnV6MmJGWEJ6dTR3QTcyZ1ZjQkUzazUzUDNfckw4VUVKRC0tLUpyV2ZtRGotRHk4OWhHQmYwa0U0YzdfYXpn?oc=5", "source_name": "Stock Titan", "published_at": "2026-05-13T07:00:00+00:00", "published_display": "13 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Carsgen\u2019s zevor-cel CAR T shows long-term survival in MM", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOa2UtdEpNckphdjgwM2JFS0dYSzM2bGZtWU5GZUNPN3BHNngzZThzSTBEbTdSWE13dVlzOXEwQVlURXNpV29pazNTNERLY2t2UzdrQWhGRGxqNm5tTUhKTHBLV3I3YnkzZzMyQUJzS1RmdnV3TzU1WDRHZ19BaDVOV3NxNktKTU9FaGN0WEJFa1dzTS1PbmsxSkFlSkM?oc=5", "source_name": "BioWorld News", "published_at": "2025-09-23T07:00:00+00:00", "published_display": "23 Sep 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CARsgen Therapeutics Announces 2025 Interim Results", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxQRVZ0STNQMjdUZ0F2eG5NUUQ5cVU2cFRDVi1jaWJrdzBjSnRuSS1yS2cybWRHWmNKb2FnaFppRXotTTJaTlpUMkpmSXNoMkY1QWVibXJXZVNxQ3Iza2hTZEktMG5PWWJvVHZYLUZqYVlGTTh1OWZxTGZkajZ3WnVxVWU3a2dvVHVKNDNTWWJBazVXMDAxOXVaY0tJTFhpbkU4YmV5bk9xNV81UTQ?oc=5", "source_name": "PR Newswire", "published_at": "2025-08-14T07:00:00+00:00", "published_display": "14 Aug 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CARsgen Successfully Defends Its GPC3 CAR-T Patent at the EPO", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxOZE9uU0ZMWkdHLXNvRDdnLU5qemZHaHBJZTB6ZlpVa1hKcktTYXZCR291bzBZVUhfNHp0YU9zV3RxWXFaeHd3SVItZlNVQnlJQ25ycGI1SDVGYTgwMVBBQV95VTYwZmFWZU80bUxIQzZyZzI5bHlSU1R3MEFLMktNUVZtVzVZM1dJd2puanhzcmVxY1I0WFdsdlVNSHZjZTh0cms3ZHRLLUpYUXBoRGktVUtQZmRaNDEx?oc=5", "source_name": "PR Newswire", "published_at": "2025-07-13T07:00:00+00:00", "published_display": "13 Jul 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CARsgen touts phase 2 stomach cancer win for cell therapy, revs up for China submission", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxNc2JjRmpRNWw2c0FQT1EtMXg4T0NFcUZHRHFrZ1JYb1BmM1NONlRzNUlpTkVvNVljVWJ6aFpoMHZMYk9YcXBkR0Zvb1Fob1ZxTzJrM0xoTTI3c25vV01WYzU3SjlPdnliOUZMODhuMVB0aTN2Nk05M3VJSHJMUEdGQ09SQ0U4ZGJpekIyRmFVVnJ1R0xndGZRU1JvdVJpM0pEcVZ2a3F5S3ZSSjR0SUplWEVuTHo2WHFQbVpv?oc=5", "source_name": "Fierce Biotech", "published_at": "2025-01-02T08:00:00+00:00", "published_display": "02 Jan 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "FDA Removes Clinical Holds Previously Placed on 3 of CARsgen's Oncology Cell Therapies", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxQNkVKZTU1TXVVNWk1cWdjanNrWTQtaE9fdDZ4cnNERGlXaHdlZmxTaGJRUDMyeVZ2RGdKalV0bGVnN3ByUzdxVTc1V01pdnZ5bWRCenFFSWVZREdHZE5jVWVOcS05M1pCV2lRSzNacWdENDNpTFczQ2hja1cyR1Axd3BBZFJ3bmlORDBNS3JWaE10S195VFpwMW9MQjI?oc=5", "source_name": "CGTLive\u00ae", "published_at": "2024-11-07T08:00:00+00:00", "published_display": "07 Nov 2024 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CARsgen Therapeutics officially listing on HKEX", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxQTFB5bnpOUnU2clR2X00yNU9PNGNvQ1lLUDhxMEJWdHkyVExWZUFoNHUwUUNWY1A5dGpRdWhHX2VDSXYyUHlmcFFaQUwwUHAzVDhNNU5HSDQwS3lxczE5Tnp0NnFYemphcWpidmJYVldhM1FnSlFtMkI3S2gzVlVLTmNSczJjTWpmR2hfX21xRndaZTJq?oc=5", "source_name": "BioPharma APAC", "published_at": "2021-06-19T07:00:00+00:00", "published_display": "19 Jun 2021 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 78, "total_relevant": 15, "sentiment_summary": {"positive": 0, "negative": 0, "neutral": 15, "score": 50, "total": 15, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 83, "events": [{"event": "general", "label": "Market update", "weight": 5.5, "count": 10}, {"event": "regulatory", "label": "Regulatory and legal", "weight": 1.1, "count": 2}, {"event": "earnings", "label": "Earnings", "weight": 1.1, "count": 2}, {"event": "capital_return", "label": "Capital return", "weight": 0.55, "count": 1}], "positive_events": 0, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 15.49, "latest_week": "2026-07-10", "one_week_move": -2.5, "four_week_move": 3.1, "twelve_week_move": -37.8, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -0.641324, "market_dynamics_buy_signal": false, "relative_strength": -8.252176, "fair_value_gap": 29.0, "fair_value_label": "Materially above fair value", "fair_value_tone": "negative", "expectation_direction": "undecided", "expectation_probability": 52.0513, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-2.5% over one week, +3.1% over four weeks, trend inactive, and materially above fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 59, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "PR Newswire", "count": 3}, {"label": "Stock Titan", "count": 2}, {"label": "Moomoo", "count": 2}, {"label": "simplywall.st", "count": 2}, {"label": "Investing.com", "count": 1}, {"label": "BioSpace", "count": 1}, {"label": "BioWorld News", "count": 1}, {"label": "Fierce Biotech", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 15}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 10}, {"label": "Regulatory and legal", "count": 2}, {"label": "Earnings", "count": 2}, {"label": "Capital return", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "50/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "83/100 classification confidence."}, {"label": "Company focus", "value": "15", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-2.5% over one week, +3.1% over four weeks, trend inactive, and materially above fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Mineralys Therapeutics CMO Rodman sells $65,781 in stock"}], "updated_at": "2026-07-18T07:47:22.371801+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}